Revenue
attach_money10M USD
YoY -33.2%
SYRSSyros Pharmaceuticals, Inc.$ --
Syros Pharmaceuticals, Inc.
SYRS
$ -
-
You can review earnings summary, quarterly trends, full-year progress, and detailed income statement data.
analyticsIncome Statement Summary
FY2023 Full YearUpdated: 12/31/2023
Operating Income
bar_chart-129M USD
YoY +5.1%
Net Income
verified-165M USD
YoY -73.9%
EPS
pie_chart-5.81USD
YoY +22.4%
Quarterly Performance
Quarterly revenue and net income trend
RevenueOperating IncomeNet Income
No quarterly data available
Full-Year Progress
Net Income Progress78.7%On Track
Revenue Progress0
Revenue Forecast450,000
Net Income Progress-33.4M
Net Income Forecast-42.5M
Income Statement Details
Item
Revenue
Cost of revenue
Gross profit
Research & development
Selling & marketing
Selling, general and administrative
Other operating expenses
Operating income
Interest expense
Income before tax
Income tax expense
Net income
Unlock Long-Term Income Statement Data
Your current plan allows viewing financial data for the latest 1 year (annual only). Upgrade to the Standard Plan to view up to 3 years (including quarterly data), or the Premium Plan to access all historical data.